Characterization of platelet aggregation in whole blood of laboratory animals by a screen filtration pressure method

Platelets

Volumn 14, Issue 4, 2003, Pages 239-246

  Sudo, Toshiki ^a   Ito, Hideki ^a   Kimura, Yukio ^a  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN;

ARTICLE; BLOOD SAMPLING; DOG; EXPERIMENTAL ANIMAL; FILTRATION; GUINEA PIG; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA;

ADENOSINE DIPHOSPHATE; ANIMALS; BLOOD; COLLAGEN; FILTRATION; HUMANS; KINETICS; NEPHELOMETRY AND TURBIDIMETRY; PLASMA; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; SPECIES SPECIFICITY;

ANIMALIA; CANIS FAMILIARIS; CAVIA PORCELLUS; ORYCTOLAGUS CUNICULUS; SUS SCROFA;

EID: 0038048505     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/0953710031000118885     Document Type: Article

References (26)

1. Born G V R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-9.
2. Cardinal D C, Flower R J. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980; 3: 135-58.
3. Kundu S K, Heilmann E J, Sio R, Garcia C, Davidson R M, Ostgaard R A. Description of an in vitro platelet function analyzer PFA-100. Semin Thromb Hemost 1995; 21 (Suppl 2): 106-12.
4. Ozeki Y, Sudo T, Toga K, Nagamura Y, Ito H, Ogawa T, Kimura Y. Characterization of whole blood aggregation with a new type of aggregometer by a screen filtration pressure method. Thromb Res 2001; 101: 65-72.
5. Swank R L. Alteration of blood on storage: measurement of adhesiveness of 'aging' platelets and leukocytes and their removal by filtration. New Engl J Med 1961; 265: 728-33.
6. Swank R L, Roth J G, Jansen J. Screen filtration pressure method and adhesiveness and aggregation of blood cells. J Appl Physiol 1964; 19: 340-6.
7. Dhall D P, Engeset J, McKenzie F N, Matheson N A. Screen filtration pressure of blood - an evaluation. Cardiovasc Res 1969; 3: 147-54.
8. Dhall D P, Matheson N A. Platelet aggregate filtration pressure - a method of measuring platelet aggregation in whole blood. Cardiovasc Res 1969; 3: 155-60.
9. Sudo T, Ito H, Ozeki Y, Kimura Y. Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method. Br J Pharmacol 2001; 133: 1396-404.
10. Qi R, Yatomi Y, Ozaki Y. Effects of incubation time, temperature, and anticoagulants on platelet aggregation in whole blood. Thromb Res 2001; 101: 139-44.
11. Rile G, Yatomi Y, Qi R, Satoh K, Ozaki Y. Potentiation of ibudilast inhibition of platelet aggregation in the presence of endothelial cells. Thromb Res 2001; 102: 239-46.
12. Kunishima T, Musha H, Aoyagi H, Kongohji K, Imai Y, Ozawa A, Soh T, Murayama M. Evaluation of the efficacy of antiplatelet drugs for ischemic heart disease patients. Jpn Circ J 2001; 65 (Suppl. 1A): 259.
13. Inoue T, Hayashi M, Uchida T, Takayanagi K, Hayashi T, Morooka S. Significance of platelet aggregability immediately after blood sampling and effect of cigarette smoking. Platelets 2001; 12: 415-8.
14. Kondoh R, Konno S, Koizumi D, Mizuno M. Effects of anti-platelet agents on platelet aggregability determined by a screen filtration pressure method with a new type of whole blood aggregometer. Jpn J Stroke 2001; 23: 307-15.
15. Kimura Y, Tani T, Kanbe T, Watanabe K. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneim Forsch 1985; 35: 1144-9.
16. Sudo T, Tachibana K, Toga K, Tochizawa S, Inoue Y, Kimura Y, Hidaka H. Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity. Biochem Pharmacol 2000; 59: 347-56.
17. Mase K, Yanagihara F, Asada T, Yamanaka Y, Yoshioka M, Yasunaga K. Evaluation of platelet aggregation test by grading curve. Rinsho Byori 1992; 40: 857-62.
18. Imiya M, Matsuo T. A new parameter for evaluating platelet aggregation in patients with chronic cerebral infarction. Rinsho Byori 1993; 41: 923-9.
19. Kurata M, Ishizuka N, Matsuzawa M, Haruta K, Takeda K. A comparative study of whole-blood platelet aggregation in laboratory animals: its species differences and comparison with turbidimetric method. Comp Biochem Physiol 1995; 112C: 359-65.
20. Cook N S, Zerwes H, Tapparelli C, Powling M, Singh J, Metternich R, Hagenbach A. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Thromb Haemost 1993; 70: 531-9.
21. Riess H, Braun G, Brehm G, Hiller E. Critical evaluation of platelet aggregation in whole human blood. Am J Clin Pathol 1986; 85: 50-6.
22. Taylor R R, Strophair J, Sturm M, Vandongen R, Beilin L J. Time dependence of whole blood aggregation in response to platelet activating factor (PAF). Thromb Haemost 1988; 59: 162-3.
23. Santos M T, Vallés J, Aznar J, Pérez-Requejo J L. Role of red blood cells in the early stages of platelet activation by collagen. Thromb Haemost 1986; 56: 376-81.
24. Setiabudy-Dharma R, Funahara Y. Enhancement of collagen-induced aggregation of platelets in whole blood. Thromb Res 1986; 42: 621-34.
25. Vallés J, Santos M T, Aznar J, Martínez M, Moscardó A, Piñón M, Broekman M J, Marcus A J. Platelet-erythrocyte interactions enhance αIIbβ3 integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo. Blood 2002; 99: 3978-84.
26. Abbate R, Favilla S, Boddi M, Costanzo G, Prisco D. Factors influencing platelet aggregation in whole blood. Am J Clin Pathol 1986; 86: 91-6.